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Highlights 
 Rainbow trout CK-2 has two differentially expressed alleles, referred to here as CK-2 and CK-2.1 
 CK-2 and CK-2.1 transcripts are both present in vitro and in vivo but display tissue/cell culture dependent 
expression in both control and PHA stimulated samples 
 A polyclonal antibody to recombinant CK-2/CK-2.1 was developed. 
 CK-2/CK-2.1 protein production was only observed in the brain, liver and head kidney of PHA stimulated 
rainbow trout samples.  
 Both peripheral blood leukocytes and the RTS-11 cell line migrated towards recombinant CK-2 in a 
concentration dependent matter 
 
Abstract (At 282 words right now, max 400 words) 
 
 Rainbow trout chemokine 2 (CK-2) is currently the only known CC chemokine to have a mucin stalk. 
Further analysis of the mucin stalk region revealed a second, related CC chemokine sequence, denoted here as 
CK-2.1. This second sequence was determined to be an allele of CK-2 following genomic PCR analysis on 
several outbred individuals. Furthermore, in both in vivo and in vitro trials, CK-2 and CK-2.1 were both present, 
but appeared to have differential tissue expression in both control and PHA stimulated samples. Upon the 
development of a polyclonal antibody to rCK-2, CK-2 was only observed in the brain, liver and head kidney of 
PHA stimulated rainbow trout tissues. In comparison, when using the rainbow trout monocyte/macrophage-like 
cell line, RTS-11, CK-2 protein was observed in both control and PHA stimulated conditions. When studying the 
function of CK-2, a chemotaxis assay revealed that both peripheral blood leukocytes and RTS-11 cells migrated 
towards rCK-2 significantly at all concentrations studied when compared to truncated β2m. Interestingly, this 













chemokine receptors may become desensitized when overstimulated as has been observed in mammalian 
models. The observed chemotactic function was indeed due to rCK-2 as cell migration was inhibited through 
pre-treatment of both the cells and the polyclonal antibody with rCK-2. As has been observed thus far with all 
other chemokines, CK-2 does appear to function through binding to a G-coupled protein receptor as chemotaxis 
could be inhibited through pre-treatment with pertussis toxin. Overall, the results of this study indicate that CK-2 
is a functional chemokine that is encoded by two differentially expressed alleles in rainbow trout, CK-2 and CK-
2.1. 
 




The immune system of vertebrates is tremendously complex, involving numerous cell types, barriers and 
specialized systems which are all used to prevent the entry and colonization of foreign entities throughout the 
body. The function of this vast network is dependent upon the ability of immune cells to migrate and interact 
with one another, a role fulfilled by extracellular mediators known as chemokines. Chemotactic cytokines, or 
chemokines, are a large family of small cytokines responsible for controlling the migratory patterns and 
positioning of immune cells (reviewed in Griffith et al, 2014). Chemokines were originally believed to have only 
pro-inflammatory functions but further study has revealed that these small proteins also play critical roles in both 
tissue homeostasis and development (Tachibana, et al, 1998, Gouon-Evans et al, 2002, Virgintino et al, 2013). 
Regardless of their specific function, all chemokines initiate their actions through binding to appropriate 
receptors which can be located on a variety of cell types. Of the chemokine receptors discovered thus far, all 
belong to the family of pertussis toxin (PTX) sensitive, G-coupled protein receptors (GCPR) (reviewed in Rossi 
and Zlotnik, 2000). 
In the highly-studied mammalian model, 46 chemokine genes are currently known (reviewed in Zlotnik et al, 
2006, Nomiyama et al, 2010) and are segregated into four families based on their differences in their structure 
and function. The largest family are the CC chemokines, so named because the first two of four cysteine residues 
are found adjacent to each other in members of this group. In comparison, a second family, called the CXC 
chemokines, has a single amino acid residue located between the first two cysteines. The third family of 
chemokines, the CX3C family, consists of a single member, fractalkine. Like the nomenclature of the previous 
families, the CX3C group has three amino acid residues separating the first two cysteines of these molecules. The 
fourth and final family of chemokines has a single cysteine residue and consists of one member, lymphotactin 
(reviewed in Charo and Ransohoff, 2006). Of these many mammalian chemokines, there are only two known to 
contain a mucin stalk: fractalkine and CXCL16 (Bazan et al, 1997, Matloubian et al, 2000). The mucin stalk can 
play an interesting role in chemokine function as it enables both membrane bound and extracellular forms of the 
attached chemokine depending on cleavage in this region (Haskell et al, 2000, Yoneda et al, 2003). 
Recently, there has been a great deal of interest pertaining to the characterization and study of chemokines in 
teleost species (Laing and Secombes, 2004). As the largest group of vertebrates, consisting of almost 26,000 
species (McKenzie et al, 2011), obtaining a deeper understanding of the function and diversification of teleost 
chemokines could provide insight into the origins and evolution of these small proteins. Since the discovery of 
the very first teleostean chemokine in rainbow trout (Dixon et al, 1998) several chemokines have been revealed 
in multiple teleost species including eighteen in rainbow trout, thirty in Atlantic salmon, and eighty-one in 
zebrafish (Peatman and Liu, 2007, Nomiyama et al, 2008, Bird and Tafalla, 2015). As chemokines have been 
recognized as one of the eight most rapidly evolving proteins (Waterston et al, 2002) clear orthologues between 
fish and mammalian counterparts are rarely observed. As a result, the function of each newly discovered 
chemokine in individual teleost species must be experimentally determined.  
A unique CC chemokine in rainbow trout is CK-2.  The rainbow trout CK-2 gene was discovered in 2002 
and is the only CC chemokine known to have a mucin stalk (Liu et al., 2002).  In the original description of this 













either alternative splicing or from an allele.  In this study, a CK-2 allele has indeed been discovered and is 
designated CK-2.1.  Whether these chemokines are functional is of special interest because of their mucin stalks 
but to date CK-2 functions have yet to be explored. Therefore, another aspect to our study has been the 
generation of recombinant CK-2 and a polyclonal antibody to CK-2.  Together these reagents have allowed the 





2. Materials and Methods 
2.1 Fish 
Rainbow trout (150-200 g) were obtained from Mimosa Springs Hatchery (Guelph, ON) and kept in 
200 L freshwater flow-through tanks at the University of Waterloo. All fish were kept and handled under a 
permit from the University of Waterloo Animal Care Committee according to CCAC guidelines. Blood was 
drawn from the caudal vein after anesthesia with 0.01% MS-222 and tissue samples either had leukocytes 
isolated immediately or were collected in RNA Later and stored at -80oC for later use. All procedures were 
performed following guidelines of the Animal Care Committee of the University of Waterloo.  
2.2 Maintenance of cell lines 
Three cell lines were used for these studies: the gonadal fibroblast RTG2 (Wolf and Quimby, 1962), the 
spleen monocyte/macrophage RTS11 (Ganassin and Bols, 1998) and the spleen stromal RTS 34 ST 
(Ganassin and Bols, 1999).  The cell lines were routinely maintained in the basal medium L15 with a 
supplement of fetal bovine serum (FBS) as recently reviewed (Bols et al., 2017). 
2.3 Determination of CK-2 genotypes 
Genomic DNA was extracted from RTS-11, RTG2, RTS 34 ST and from the whole blood of 55 
individual rainbow trout as described by Sambrook et al, 1989. It was previously observed by Liu et al 
(2002) that there are at least two copies of CK-2 in rainbow trout. These variants differed in size, thus 
primers were developed to further explore the origin of this variability. The four primer sets used in this 
study (Table 1) flanked the mucin stalk which amplified the region containing the size difference between 
CK-2 and CK-2.1. The PCR parameters were as follows: 95C for 5 min; 30 cycles of 95C for 30 seconds 
(sec), the appropriate annealing temperature for the primer pair for 30 sec (see Table 1) and 72C for 1 min 
followed by a final elongation of 72C for 5 min. The amplified PCR products were run on a 1.5% agarose 
gel containing 0.1% ethidium bromide (EtBr) and the DNA bands were visualized with a UV 
transilluminator containing an EtBr filter. Based on the band sizes, rainbow trout individuals and cell lines 
were determined to be homozygous for CK-2, homozygous for CK-2.1 or heterozygous. 
Upon genotyping of the 55 outbred rainbow trout for CK-2/CK-2.1, the data was assessed to determine 
whether the alleles were in Hardy-Weinberg Equilibrium using the equation of p2 + 2pq + q2 = 1 where p 
represented the frequency of CK-2 and q represented the frequency of CK-2.1.  
2.4 Peripheral blood leukocytes (PBL) and head kidney leukocytes (HKL) isolation 
Peripheral blood leukocytes (PBLs) were separated by density gradient centrifugation using Histopaque 
1077 (Sigma-Aldrich) according to the manufacturer’s instructions. Cells were stained with trypan blue to 
determine viability and counted using a hemocytometer (Hausser Scientific) to give a final concentration of 
1x107 live cells/ml in L-15 medium supplemented with 20% FBS, 100 U/ml of penicillin and 100 U/ml of 
streptomycin. Head kidney leukocytes were isolated in the same manner at a density of 1x107 cells/ml in 
RPMI-1640 medium containing 25 mM Hepes, 10000 U/ml penicillin, 10 mg/ml streptomycin and 200 
units/ml of heparin sodium salt.  
2.5 Studying CK-2 and CK-2.1 transcript expression in vivo and in vitro 
 Reverse-Transcription Polymerase Chain Reaction (RT-PCR) was performed to study the expression of 
CK-2 and CK-2.1 in vivo and in vitro and in response to the plant lectin, phytohemagglutinin (PHA).  
To detect variations in expression of CK-2 following stimulation in vivo, six heterozygous rainbow trout 













non-stimulated fish (PBS injected) were sacrificed at the time of injection (0hr), and two stimulated fish 
were sacrificed at 4hr, 8hr, and 24hr after stimulation so that head kidney (HK), spleen and brain samples 
could be obtained for each of these time points.   
 To detect in vitro expression of CK-2 and CK-2.1, as well as potential upregulation in response to PHA, 
primary PBL and HKL were isolated as described in section 2.4. Pre-screened rainbow trout containing all 
three possible allelic combinations were chosen for this experiment and both blood and head kidney samples 
were obtained from each fish to isolate leukocytes. For each of the three possible genotypes, both PBLs and 
HKLs were plated in a 6-well cell culture plate at a density of 1x107 cells/well. Following overnight 
adherence at room temperature (RT), all experimental plates were treated with 10μg/ml PHA per well while 
control plates were treated with an equivalent volume of 1X phosphate buffered saline (PBS) for 24 hours. 
RNA was extracted from both the control and stimulated plates to be used for RT-PCR expression analysis. 
 Transcript expression of CK-2 and CK-2.1 was also analyzed in vitro using the RTS-11, RTG2 and RTS 
34 ST cell lines. For experimental use, RTS-11 was plated in 6-well cell culture plates at a density of 1x107 
cells/well while RTG2 and RTS 34 ST were both seeded at a density of 3x105 cells/well. Following 
overnight adherence at RT for RTS-11 and 18oC for RTG2 and RTS 34 ST, experimental wells were 
stimulated with 10 μg/ml PHA per well while control plates were treated with an equivalent volume of 1X 
phosphate buffered saline (PBS) for 24 hours. RNA was then extracted from both the control and stimulated 
plates as described below.  
2.5.1 RNA extraction and cDNA synthesis 
 Depending on the sample used, either 50 mg of tissue or a cell pellet containing a maximum of 1 x 107 
cells was homogenized in 1 ml of Trizol reagent and RNA was extracted according to the manufacturer’s 
protocol (Invitrogen). To shear genomic DNA, the RNA sample was passed through a 23-gauge needle 5 
times. The RNA was dissolved in 20 μl of DEPC water and stored at -80oC until used.  
 A RT-PCR kit (Fermentas) was used to synthesize cDNA from RNA as per the manufacturer’s protocol. 
This procedure was followed by a PCR reaction using forward and reverse primers spanning an intron to 
detect potential genomic DNA contamination (see Table 1) using the same PCR protocol as described above 
in section 2.3. As an internal control, PCR was performed using primers for elongation factor alpha (EF1-α) 
as outlined in Table 1. For this control gene, the PCR parameters were as follows: 30 sec at 95oC, 30 cycles 
of 94oC for 40 sec, 30 sec at 54oC, 1 min at 72oC and a final elongation of 5 min at 72oC. 
2.6 Development of polyclonal antibodies to CK-2 
 2.6.1  Construction of CK-2 expression vector 
  The full coding region of CK-2 was amplified using PCR primers designed to contain BamHI and 
HindIII sites in the sense and antisense primers respectively using rainbow trout blood cDNA as the template. 
The amplified PCR product was ligated into pGEM T-easy (Promega) and sequenced at the center for 
Applied Genomics (Toronto, ON, CA) to confirm the sequence identity. The CK-2 sequence was excised and 
ligated into the expression vector, pRSET A, and then transformed into BL21 (DE3) Escherichia coli as 
described previously by Sever et al, 2013.  
 2.6.2  Production and purification of recombinant CK-2 
Fifty milliliters of overnight culture grown at 37oC was used to inoculate 500 ml of LB broth. The 
cells were grown until the OD600 reached 0.5 and then induced with Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at a final concentration of 1 mM. Following induction, the cells were grown for another 5 h and 
harvested by centrifugation at 10,000 rpm for 10 min. Protein was purified using Ni-NTA Agarose (Qiagen, 
Mississauga, ON) according to manufacturer’s instruction. Briefly, one ml of Ni-NTA Agarose resin was 
added to 10 ml of cleared cell lysate and incubated for 1 h at 4 C. After incubation, the lysate was loaded onto 
a 25 ml econocolumn (Bio-Rad) and washed with binding buffer (100 mM NaH2PO4, 10 mM Tris, 8 M urea) 
equilibrated to pH 8.0, pH 6.3, and pH 5.9. Finally, recombinant CK-2 (rCK-2) was eluted at pH 4.5 and was 
stored at 4oC. The elution fractions were separated on a 17% sodium dodecyl sulfate (SDS) polyacrylamide 
gel electrophoresis. Following SDS-PAGE, the proteins were transferred onto a nitrocellulose membrane 
blocked with 5% skim milk in TBS-T buffer (0.14 M NaCl, 2.7 mM KCL, 25 mM Tris, 0.5% Tween 20, pH 













express antiserum (Invitrogen, Carlsbad, CA) to identify the specific Xpress epitope tag on the recombinant 
protein. 
 2.6.3  Production of polyclonal antibodies to CK-2  
Two New Zealand white rabbits (Charles River, ON, CA) were injected intramuscularly with an initial 
dose of 0.5 mg of rCK-2 with Freund’s complete adjuvant (1:1). A boost using 0.5 mg rCK-2 with Freund’s 
incomplete adjuvant (1:1) was given every three weeks. Rabbits were exsanguinated after 12 weeks with ear 
bleeds performed every three weeks to verify the antibody titer.  
To determine the specificity of the antibody, extracts from rainbow trout tissues (as described in 2.6.3) 
were prepared, run on an SDS-PAGE gel and transferred to nitrocellulose membranes (Bio-Rad) for western 
blot analysis. The nitrocellulose membranes were incubated with or without recombinant CK-2 protein (0.5 
mg/ml) added to the polyclonal antiserum. When the recombinant protein was absent, bands of 36, 98 and 
~250 kDa were detected (see Fig. 5). No bands were detected when the rCK-2 protein was present. Thus all 
bands detected with the developed antibody are variants of CK-2 or CK-2.1. It is anticipated that multiple 
isoforms may be detected by this antibody due to its polyclonal nature. Further, blots with recombinant CK-2 
were probed with pre-immune serum, crude anti-CK2 at a 1:5000 dilution and affinity purified anti-CK2 at a 
1:50 dilution.  
2.7 CK-2 protein levels in vivo and in vitro 
 Western blotting with the antibody prepared in the above section was used to study the expression of 
the CK-2 proteins in vivo with and without 24 h PHA stimulation and in vitro with PHA stimulated RTS11 
cultures with and without FBS. Rainbow trout heterozygous for CK-2 and CK-2.1 received intravenous (i.v.) 
injections of PHA at a final concentration of 50g per 250g of body weight. Control fish received an i.v. 
injection of 100 μl of 1X PBS. After 24 hours, fish were sacrificed and head kidney (HK), liver, peripheral 
blood leukocytes (PBL), brain, spleen, intestine, muscle, and heart were collected. Protein was extracted 
from these tissues for western blot analysis. RTS-11 cells exposed to PHA in same manner as described 
above for transcript expression analysis. Following 24 h stimulation, protein was extracted from control and 
test wells and subject to western blot analysis as described below.  
  For protein extraction, 300 ml of NP-40 lysis buffer (1% (v/v) NP-40, 150 mM NaCl, 50 mM Tris [pH 
8.0]) supplemented with 1X protease inhibitor cocktail (Roche) was added to either 70 mg of tissue or a cell 
pellet containing approximately 2 x 107 cells. Tissues were homogenized through sonication on ice in short 
bursts and crude lysates were cleared by centrifuging at 4oC for 20 min at 14,500 rpm. Supernatants were 
collected and the protein concentrations were quantified using the bicinchoninic acid (BCA) assay (Thermo 
Fisher) following the manufacturer’s protocol. Tissue lysates (50 mg) were mixed with 5X Laemmli sample 
buffer and boiled for 10 min prior to loading. Samples were separated on a 12% acrylamide gel, transferred 
to nitrocellulose membranes and subsequently blocked with 5% skim milk in TBS-T (0.14 M NaCl, 2.7 mM 
KCl, 25 mM Tris, 1% Tween 20; pH 7.5) for 1 hour. Blots were probed with primary antibody for 1 hour 
using purified CK-2 antisera at dilution of 1:50. The membranes were washed with TBS-T three times for 10 
min each then the secondary antibody, goat anti-rabbit alkaline phosphatase (Sigma Aldrich), was applied at 
a 1:30000 dilution and probed for 1 hour. Bands were detected using NBT/BCIP (Roche) according to 
manufacturer’s instructions. 
2.8 Elucidating the function of rainbow trout CK-2 using a chemotaxis assay 
To observe the impact of CK-2 on the chemotaxis of RTS-11 and peripheral blood leukocytes, a 48-
well micro chemotaxis assembly (NeuroProbe) was used. The wells of the lower chamber were filled in 
triplicate with either 50 ng/ml 100 ng/ml or 500 ng/ml or 1μg/ml of CK-2 suspended in 1X PBS. For each 
concentration of CK-2, the same concentration of recombinant truncated β2m protein (as developed by 
Kales et al, 2006) suspended in 1X PBS was used as a negative control to confirm that any cell migration 
was due to CK-2 and was not resulting from the chosen method of recombinant protein production. Another 
negative control containing 1X PBS alone was also used while either zymosan activated serum (ZAS) or 
complement factor C5a were used as positive controls. The wells of the top chamber were filled with 45 μl 
of L-15 containing 1 x 107 cells/ml and the two chambers were divided by a polyvinylpyrrolidone (PVP) 
free polycarbonate membrane with a pore size of 5 μm. The assembly was then incubated for 1 hour at 













The filter was then fixed in methanol for 1 minute and stained with 1% Giemsa (dissolved in 100% ethanol) 
for 1 hour. After staining, the filter was washed twice with deionized water, fixed with Permount (Thermo 
Fisher) and mounted on a microscope slide. Cells which had migrated to the bottom side of the filter were 
counted in a total of five different fields per well at a magnification of 400x. The chemotactic index was 
calculated by dividing the total number of migrating cells in the test wells by the number of cells that 
spontaneously migrated toward the PBS negative control.  
To provide further validation for the results of the chemotaxis assays, RTS-11 or primary PBLs were 
incubated with either CK-2 (100 ng/ml) alone or CK-2 (100 ng/ml) with pertussis toxin (100 ng/ml) as 
PTX is known to inhibit chemotactic function. After the 1 hr incubation time at RT, the PBLs were washed 
twice with 1X PBS and resuspended in L-15 to a final concentration of 1 x 107 cells/ml for use in the 
chemotaxis assay as described above. To show that the observed migration towards CK-2 and CK-2.1 was 
not due to the mucin stalk, PBLs were incubated with both proteins alone (500 ng/ml) as well as with the 
mucin stalk of CK-2.1 alone (1 μg/ml) and chemotaxis was measured as described above.  
2.9 Statistical analysis 
Statistical analysis was performed using a one-way ANOVA followed by Fischer’s Least Significant 
Difference (LSD) post hoc test to determine if there was a significant change of CK-2 or CK-2.1 between 
groups. For the chemotaxis assays, after the data was transformed by taking the natural logarithm to achieve 
equal variance and normality, a one-way ANOVA was performed followed by the LSD post hoc test to 
determine whether there was a significant change in cell migration. A probability of P<0.05 was considered 
statistically significant.  
3. Results 
3.1  Isolation of the CK-2.1 sequence and its prevalence in rainbow trout 
When cDNA primers that spanned the mucin stalk region of rainbow trout CK-2 were employed, a 
doublet was observed. To examine the nature of this possible second chemokine gene, a rainbow trout 
phytohemagglutinin (PHA) stimulated head kidney cDNA library was screened with a full-length clone of 
CK-2. This analysis revealed a new cDNA clone that was isolated and sequenced. The 702 nucleotide (nt) 
open reading frame encoded a putative 233 amino acid (aa) protein that shared sequence similarity with 
known chemokines in both mammals and fish, but most notably it shared 99% amino acid sequence 
similarity with rainbow trout CK-2 in overlapping regions. When this newly discovered clone, referred to as 
CK-2.1, was aligned with CK-2, the differences between the two amino acid sequences resided in the mucin 
stalk regions where the CK-2.1 sequence encoded an extra 42 amino acids with 53 possible O-glycosylation 
sites (Fig. 1A).  
When 55 rainbow trout individuals were screened using the CK-2 primers that spanned the mucin stalk 
region, both the smaller CK-2 band (600 bp) and the larger band of CK-2.1 (726 bp) are visible, with some 
individuals expressing both of these bands (Fig. 1B) indicating that these may be two separate alleles of the 
same gene. Using the Hardy-Weinberg equation with the observed data, the two alleles appear to be in 
equilibrium within the studied rainbow trout population [(0.42)2+2(0.42)(0.58)+(0.58)2=1] but a larger 
sample size of wild outbred fish may be required to confirm this.  
3.2  Induction of CK-2 and CK-2.1 transcripts in cell cultures by PHA   
When added to HKL primary cell cultures at a concentration of 10 μg/ml, the plant lectin, 
phytohemagglutinin, was able to significantly increase the gene expression of CK-2 and CK-2.1 alone, or 
both alleles in the case of heterozygotes (p = 0.016) as detected by RT-PCR (Fig. 2A). In contrast, when 
receiving the same treatment, the PBL primary cell cultures exhibit equal expression of both of these alleles 
before and after stimulation (Fig. 2B). This pattern was observed in both homozygotes and heterozygotes. 
To detect the transcript expression of the CK-2 allele in different rainbow trout cell lines, it was 
important to first determine which alleles were present within each cell line. After PCR amplification using 
genomic DNA, it was shown that RTS-11 contains CK-2 alone, while RTG2 only has the CK-2.1 allele. In 
comparison, RTS 34 ST was heterozygous, containing both CK-2 and CK-2.1 alleles (Fig. 3A). To further 
study the induction of the CK-2 allele, RTS-11 was stimulated with 10 μg/ml of PHA. When 20% FBS was 
present within the culture media, expression of CK-2 did not appear to be significantly influenced by 












be a trend towards reduced expression of CK-2 following stimulation with PHA (Fig. 3B).  In comparison, 
when RTS-11 was stimulated with PHA in media lacking FBS, a significant decrease in CK-2 transcript 
expression was observed at 24-hours post-stimulation as detected by RT-PCR (p = 0.046) (Fig. 3C). 
Interestingly, despite RTG2 having the CK-2.1 allele alone, and RTS 34 ST being heterozygous for both 
alleles, nether of these cell lines displayed an increase in transcript expression of either gene when exposed 
to 10 μg/ml of PHA (Fig. 3D and E).   
3.3 Induction of CK-2 and CK-2.1 transcripts in fish by PHA 
Following injection with PHA (50 μg/250 g body weight), CK-2 gene expression in heterozygous 
rainbow trout had variable results depending on the tissue studied. In both head kidney and brain, there was a 
strong and relatively even expression of both CK-2 and CK-2.1 in the unstimulated fish (0 hr) that declined 
steadily after stimulation (Fig. 4A and 4B respectively). In stimulated spleen tissues, CK-2 expression alone 
appeared to be induced 4 hours after injection with a continuous decline thereafter. In these same spleen 
samples, CK-2.1 appeared to have consistent expression levels throughout the entire time course observed in 
both groups studied (Fig. 4C and 4D). Thus, it appears that PHA stimulation induces differential expression 
of CK-2 over CK-2.1 in the spleens of heterozygous rainbow trout.  
3.4 Induction of CK-2 protein in fish and in RTS-11 by PHA  
The induction of CK-2/CK-2.1 protein was observed in only head kidney, liver and brain of rainbow 
trout following stimulation with PHA, with each tissue producing a different size of CK-2/CK-2.1 (36 kDA 
band in liver, 98 kDa band in brain and a ~250 kDa band in head kidney) (Fig. 5Ai). Surprisingly, all of the 
bands observed indicate proteins larger than the sizes predicted by the amino acid sequences (~30 kDa for 
CK-2 and ~35 kDa for CK-2.1). In comparison, no protein production was detectable in the stimulated PBLs, 
gill or spleen tissues (Fig. 5Ai) nor in any tissues of the PBS injected control fish (Fig. 5Aii). Regardless of 
stimulation with PHA and the presence or absence of 20% FBS, RTS-11 cells produced protein bands of 
various sizes including a strong band at 30 kDa, the anticipated size of unglycosylated CK-2 (Fig. 5B). In 
both in vitro and in vivo samples, the bands observed with a larger molecular mass may be a result of 
glycosylation.  
Because bands of various sizes were observed by the developed CK-2/CK-2.1 antibody in Fig. 5Ai and 
5B, it was necessary to validate that the detected signal was indeed the protein of interest. To do this, the 
CK-2/CK-2.1 antibody was first blocked using rCK-2 prior to probing a membrane containing samples 
known to contain CK-2/CK-2.1 protein bands. The resulting lack of bands following blocking verified that 
any bands detected by the antibody (when not blocked by rCK-2), are variants of CK-2 and CK-2.1 (Fig. 
5Aiii). Recombinant CK-2 was also successfully detected when probed with pre-immune serum (Fig. 5Ci), 
crude anti-CK2 (Fig. 5Cii) and affinity purified anti-CK2 (Fig 5Ciii). Furthermore, the final, purified anti-
CK2 antibody was also able to successfully detect both rCK-2 and rCK-2.1 individually (Fig. 5Civ).  
3.5  Recombinant CK-2 induces migration of RTS-11 and rainbow trout PBLs 
After exposure to various concentrations of rCK-2 (50 ng/ml, 100 ng/ml and 500 ng/ml, 1 μg/ml,), both 
rainbow trout PBLs and the RTS-11 cell line were observed to display significant migration towards the 
recombinant CK-2 protein when compared to the non-chemokine recombinant protein, truncated β2m (Fig. 
6A and 6B respectively). Regardless of the cell type stimulated, the highest level of migration was seen 
when a concentration of 100 ng/ml of rCK-2 was used but this was not significantly different from 500 ng/ml 
or the C5a positive control. All rCK-2 concentrations analyzed were significantly different from the 
truncated β2m negative control tested at identical concentrations. Interestingly, chemotaxis was observed to 
increase from 50 ng/ml to 100 ng/ml but did not continue in a concentration dependent manner as the highest 
concentration, 1 μg/ml, displayed a chemotaxis index comparable to the lowest concentration of 50 ng/ml. 
As expected, significant migration was observed when cells were exposed to the C5a positive control while 
negligible chemotaxis was detected towards the PBS negative control.  
  To confirm whether the observed chemotaxis was due to rCK-2, various blocking experiments were 
conducted. After pre-treatment with an excess of rCK-2 to block the appropriate chemokine receptors, PBL 
chemotaxis to rCK-2 was significantly inhibited (p = 0.001, data not shown). Furthermore, if the rCK-2 was 
blocked with anti-CK2 prior to use in the chemotaxis assay, the rCK-2 was unable to induce chemotaxis of 













receptors, thus to test whether CK-2 used this mechanism, pertussis toxin (PTX), a known inhibitor of these 
receptors was used as a treatment. When RTS-11 and PBLs were exposed to both PTX and rCK-2, the ability 
of both cell types to migrate towards rCK-2 was significantly reduced to background levels (p = 0.006) (Fig. 
6C and D), indicating that CK-2 does act through G-protein coupled receptors. Lastly, to determine whether 
the mucin stalk of CK-2 influenced the chemotactic ability of the chemokine, PBLs were exposed to a 
recombinant fragment containing only the mucin domain of CK-2. When compared to the chemotaxis 
induced by CK-2 and CK-2.1 recombinant proteins alone, the mucin stalk alone failed to elicit significant 
cell migration as observed by the positive control and CK-2 or CK-2.1 alone (Fig. 6E). Furthermore, there 
was no significant difference in the number of migrating cells responding to CK-2 and CK-2.1 at a 
concentration of 500 ng/ml (Fig. 6E).  
4. Discussion 
4.1 The discovery of CK-2.1, an allele of CK-2 
  When attempting to characterize the rainbow trout CK-2 gene, northern blot analysis revealed two 
separate bands that suggested the presence of another transcript (Liu et al, 2002). It was hypothesized that this 
unexpected mRNA transcript could be derived from either alternative splicing of the CK-2 gene or from a 
separate, yet closely related gene. To further explore the origin of this alternative mRNA band, a cDNA library 
was probed and a novel chemokine was isolated and sequenced. The newly discovered chemokine sequence, 
referred to as CK-2.1, was highly similar to the known sequence of the CC chemokine, CK-2 (Liu et al, 2002), 
but it encoded an additional 42 amino acids of mucin stalk. This variation in the length of the mucin domain is 
not unusual as many mucins have been shown to exhibit this feature due to alternative splicing of their variable 
repeat region (Debailleul et al, 1998, Williams et al, 1999, Zhang et al, 2013), yet after further analysis splicing 
was not occurring in this situation. After amplifying the region surrounding the mucin stalk of CK-2.1, rainbow 
trout individuals either had CK-2 alone, CK-2.1 alone or both in proportions that were in Hardy-Weinberg 
equilibrium suggesting that CK-2.1 is an allele of CK-2 and not a separate gene. 
4.2 Expression of CK-2 and CK-2.1 in rainbow trout tissues and cell culture  
To determine whether CK-2 and CK-2.1 transcripts were regulated in either a coordinated manner or 
differentially, transcript expression was observed in both homozygous and heterozygous individuals using RT-
PCR. Northern blot analysis was not possible due to the high degree of sequence similarity between these two 
alleles that would render individual probe design and the recognition of separate bands extremely difficult. To 
investigate whether the level of expression of both CK-2 and CK-2.1 were influenced by immune challenge, 
primary HKLs and PBLs were stimulated with phytohemagglutinin, a mitogen commonly used for the 
stimulation of cell division in T lymphocytes (Movafagh et al, 2011). Regardless of whether the individual was 
homozygous for CK-2, homozygous for CK-2.1 or heterozygous, transcript expression of the chemokine 
significantly increased in HKLs but not in PBLs. This may indicate the activation status of the cell mixture in 
question, with PBLs not being fully mature while HKLs are primed and responding to the immune stimuli.  
After validating that long-term cell cultures are also capable of being homozygous or heterozygous for the CK-
2/CK-2.1 alleles, the influence of immune stimulation on transcript expression was observed. Similar to what 
was observed with PBLs, PHA stimulation did not induce expression of CK-2 in RTS-11. Instead, there was a 
continuous level of CK-2 expression over 24 hours. As RTS-11 has both monocytic and macrophage-like cells 
(Montero et al, 2008), it may be that monocytes and/or macrophages are either not responsive to stimuli due to 
their maturation state or need other cytokine signals to prime them into a state where they can produce further 
CK-2/CK-2.1. The steady level of CK-2/CK-2.1 transcript expression in RTS-11 was seen to decrease after 
removing FBS from the media. This is not surprising as FBS-supplementation is often required to observe 
chemotactic activity in mammalian cell lines thus, media lacking FBS is frequently used as a negative control in 
these studies (Alberson et al, 2013, Fang et al, 2017). This could explain the observed decrease in CK-2/CK-2.1 
transcript production in the absence of FBS despite the RTS-11 cells undergoing 24 hours of stimulation with 
PHA.  
  Interestingly, an entirely different trend was observed when looking at transcript levels of CK-2 and CK-
2.1 in whole fish tissues after the animals received i.p. injections of PHA. The head kidney had a decrease in 













reduction in expression over the following 20 hours. In both mammalian and teleostean models, PHA is known 
to primarily stimulate T lymphocytes (Mier and Gallo, 1980, Grondel and Harmsen, 1984, Siegl et al, 1993). 
From there, lymphokines and growth factors important for hematopoiesis are released from the replicating cells 
(Mier and Gallo, 1980). Following injection with PHA, perhaps T lymphocyte replication occurred at a rapid rate 
within the head kidney thus chemokines are not required to attract cells to that location. Upon production of an 
adequate T lymphocyte arsenal, these cells may have been released into the periphery to travel to the spleen as 
seen by the short-lived increase in CK-2 transcript expression at 4 hours. Based on this explanation, one would 
expect PBLs to display an increase in transcript expression of CK-2 but perhaps this would only occur between 0 
and 4 hours and was therefore not observed during the time points selected for this trial. This theorized pattern 
displays that when in vivo, the cells will be receiving all of the appropriate priming signals that cell cultures 
would not, possibly explaining some of the differences when comparing transcript expression in the in vitro 
models.  
4.3 Induction of CK-2 protein in fish and in RTS-11 by PHA 
The developed polyclonal antibody, raised against recombinant rainbow trout CK-2, was shown to cross-
react with both CK-2 and CK-2.1 recombinant protein. Given the observed differential expression of CK-2 and 
CK-2.1, heterozygous fish were chosen so that the expression pattern of both CK-2 and CK-2.1 could be 
detected. Despite the presence of both CK-2 and CK2.1 transcripts in unstimulated tissues, no detectable protein 
was observed in western blot analysis of unstimulated tissues, indicating potential post-transcriptional control of 
protein production. However, following stimulation, cross-reactive bands were seen in the head kidney, liver and 
brain while neither spleen nor PBLs showed any detectable protein production. The low levels of protein in 
unstimulated tissues corresponds to our previous work wherein there was no detectable transcript expression of 
CK-2 in unstimulated HKL and PBL by northern blot analysis (Liu et al, 2002). The fact that PHA stimulated 
PBLs express CK-2 mRNA but not the protein suggests that the cells that produce this protein are circulating 
lymphocytes. The lack of protein expression in stimulated PBLs supports the idea that these cells are not mature 
or activated and thus do not respond to stimuli as seen in the mRNA expression. Taken together, these results 
suggest that perhaps CK-2/CK-2.1 plays a pro-inflammatory role in vivo, as the CK-2/CK-2.1 protein appears to 
only be produced in response to the PHA stimulus. Contrary to what was observed in vivo, it appears that the in 
vitro model, RTS-11, was capable of producing CK-2 protein regardless of whether the cells were stimulated or 
not. Furthermore, protein levels were consistent whether FBS was present in the media or absent, a factor that 
was able to impact CK-2 transcript expression.  
When analyzing the molecular weight of the protein produced in different tissues, although heterozygous 
animals were used for all in vitro western blot analyses, only a single band was detected in the head kidney and 
brain, while the liver showed a single prominent band as well as several faint bands that might correspond to 
other allelic forms of CK-2/CK-2.1. The expected molecular weights of CK-2/CK-2.1 based on amino acid 
sequences were 30 kDa for CK-2 and 35 kDa for CK-2.1. However, there are 42 possible O-glycosylation sites 
in the mucin stalk of CK-2 (Liu et al, 2002) and 53 in that of CK-2.1, which may influence the multiple band 
sizes observed in some tissues. As expected, a 35 kDa band was detected in liver tissue, likely representing CK-
2.1, while a 98 kDa band and a larger (~250 kDa) band was also detected in the brain and head kidney 
respectively. In contrast, the protein production observed in both stimulated and unstimulated RTS-11 cells 
revealed four prominent bands, the smallest corresponded to unglycosylated CK-2, with a faint band at 35 kDa 
that could be CK2.1, while the other three were larger than 64 kDa. This variability in protein size could be 
attributed to typical characteristics of O-linked sugars, in which it has been well established that the terminal 
glycosylation sequence differs from tissue to tissue between cell types (Bennett et al, 1996, Hagen et al, 1997 
and reviewed in Rademacher et al, 1988). It has also been shown in mammals that different tissues contain 
different transferase activities (Sorensen et al, 1995) thus CK-2 could be differentially glycosylated according to 
tissue-specific expression of the different glycosyltransferases. Because the RTS-11 cell line is heterogeneous, 
containing both monocyte/macrophage-like cells (Montero et al, 2008), it may be that different cell types within 
the culture are producing the different size variants of CK-2/CK-2.1 based on the maturation stage of the cells.  
A high level of protein production was observed in the brain of stimulated rainbow trout similarly to 
what has been observed in the murine mammalian model, wherein fractalkine, the sole member of the CX3C 













neurons as well as modulating microglial activation (Ransohoff et al, 2009). When constitutively expressed, it 
appears that fractalkine plays an immunosuppressive role resulting in the inhibition of microglial activation 
(Biber et al, 2007). This is further supported through analysis of animal models with induced neuropathologies 
wherein a deficiency of fractalkine leads to an increased production of proinflammatory molecules, and thus a 
massive increase in cell death (Cardona et al, 2006, Morganti et al, 2012). At the structural level, much like CK-
2/CK-2.1, fractalkine also has a mucin stalk enabling the chemokine to have both membrane-bound and secreted 
forms (Fong et al, 2000). Further comparison of these chemokines reveals that the C terminal end (amino acids 
101-191) of CK-2 is highly similar to fractalkine, yet when the full lengths of the chemokines are aligned, CK-2 
is only 25% identical and possesses a typical CC chemokine structure. When taking all this information together, 
perhaps rainbow trout CK-2 plays a similar role in suppressing inflammatory responses as evidenced by its high 
protein levels in rainbow trout brain following stimulation.  
4.4 The impact of CK-2 on cell chemotaxis 
 Regardless of whether CK-2 is playing a stimulatory or regulatory role in immune responses, the 
defining feature of any chemokine is the capacity to coordinate the movement and positioning of immune cells 
(Griffith et al, 2014). At varying concentrations, rCK-2 was able to significantly attract both PBLs and the RTS-
11 cell line when compared to the truncated β2m negative control. Interestingly, this chemotaxis did not occur in 
a concentration dependent matter with the highest concentration (1 μg/ml) inducing less chemotaxis than 100 
ng/ml and 500 ng/ml. This phenomenon has been observed in the mammalian model wherein prolonged 
exposure to its ligand can result in the desensitization of associated chemokine receptors. In these situations, 
chemotaxis will be observed at low chemokine concentrations and will increase in a concentration-dependent 
manner. However, when the concentration becomes too high, the cells will no longer migrate towards the same 
chemoattractant. This is a believed to be a regulatory process meant to diminish the responsiveness of chemokine 
receptors as a method of protecting the cell from overstimulation (Lefkowitz, 1998, Bennett et al, 2011). The 
mechanism responsible for abolishing chemotaxis at high chemokine concentrations is currently unclear but is 
believed to be involved with agonist-dependent desensitization and endocytosis mediated by G protein-coupled 
receptor kinases and β-arrestins (Lefkowitz, 1998, Fong et al, 2002). As a similar pattern has been observed in 
this study using the rainbow trout chemokine, CK-2, perhaps a similar regulatory mechanism occurs for 
teleostean immune cells.   
Although CK-2 did induce chemotaxis in rainbow trout leukocytes, it was important to validate whether 
the different alleles and protein domains of CK-2 would play individual roles in this observed cell migration. 
When measuring the chemotactic ability of CK-2 and CK-2.1 proteins separately, there is no significant 
difference between the proteins regarding their impact on cell migration. This further validates the concept that 
although the CK-2 and CK-2.1 gene transcripts can display differential expression in rainbow trout individuals, 
the resulting function, regardless of which protein is produced, does not appear to be affected. Furthermore, the 
mucin stalk region alone was not enough to induce chemotaxis in rainbow trout leukocytes similarly to what has 
been previously observed in mammalian models where the mucin stalk of fractalkine, did not induce chemotaxis 
(Haskell et al, 2000, Volin et al, 2001). 
Given that RTS-11 was shown to produce CK-2 protein both constitutively and in response to 
stimulation, it was surprising that these cells were also shown to react and migrate towards CK-2. Due to the 
heterogeneous nature of RTS-11, containing a mixture of both immature monocytes and mature macrophages 
(Montero et al, 2008), it is possible that one population is attracted to the CK-2 that is produced by the other. 
This would be very similar to what has been observed with lymphotactin, wherein NK cells produce this 
chemokine in an effort to attract both NK cells and T lymphocytes to sites of injury (Hedrick et al, 1997). Thus, 
it is not unheard of for leukocytes to both produce a specific chemokine, as well as react to that same chemokine. 
However, before any definitive conclusions can be made regarding which cell types produce and are attracted to 
CK-2, further investigation is required.   
 
Conclusions 
This study determined that both CK-2 and CK2.1 are alleles of the same gene and that they encode a 
protein that functions as a typical chemokine. When observed together, both transcript expression and protein 













including differential expression of alleles in some tissues of heterozygous fish. Future studies will focus on 
isolating the receptor for this chemokine, as well as determining which cell types produce and respond to it. This 
will lead to a deeper understanding of teleost immunity as well as the evolution of the vertebrate immune system 
with a particular focus on chemotactic cytokines.  
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Figure 1: The relationship between CK-2 and CK-2.1 sequences. (A) The amino acid sequence alignment of 
rainbow trout CK-2 and CK-2.1 (B) PCR bands of CK-2 and CK-2.1 obtained from the genomic DNA of 10 
randomly selected rainbow trout individuals. The 700bp band represents CK-2.1 whereas the 600bp represents 
CK-2.  
Figure 2: Transcript expression of CK-2 and CK-2.1 in HKLs and PBLs primary cultures. RT-PCR analysis 
displaying transcript levels of CK-2 and CK-2.1 after stimulation with either 10 μg/ml of PHA (P) or the PBS 
control (C) for 24 hours in rainbow trout HKLs (A) and in rainbow trout PBLs (B). The term “heterozygotes” 
describes individuals that contain both the CK-2 and the CK-2.1 allele. This analysis was repeated with three 
individual fish for each genotype (n=3) with the presented gel image representing one replicate. The upper panel 
in each case shows amplification of CK-2/CK-2.1 while the lower panel presents the amplification of the control, 
EF1-α. The bar graphs below each gel image show the average ratio of expression between either CK-2 (grey bars) 
or CK-2.1 (white bars) and the EF1-α amplicons that were used as an internal standard for each time point. 
Significant difference between samples are indicated by * (P<0.05). Vertical error bars represent the standard 
error. 
Figure 3: RT-PCR Analysis of CK-2 and CK-2.1 expression in rainbow trout cell lines. (A) PCR 
amplification of genomic DNA displaying the allelic distribution of CK-2 and CK-2.1 in three rainbow trout cell 
lines, RTS-11, RTS 34 ST, and RTG2. Rainbow trout previously observed to be homozygous for CK-2, CK-2.1 
as well as heterozygous were used for the positive control lanes. (B) RT-PCR analysis showing transcript levels 
of CK-2 in RTS-11 after stimulation with 10 μg/ml of PHA during a 24-hour time course challenge when 20% 
FBS was either present in the culture media (B) or absent (C). For B, C, D and E, the upper panels represent the 
CK-2 mRNA bands while the bottom panel is the control, EF1-α. The bar graphs below each gel image (B and 
C) show the ratio of expression between CK-2 and the EF1-α amplicons that were used as an internal standard 
for each time point. All data was repeated a minimum of three times (n=3). All data was transformed into natural 
logarithm with significant differences indicated by the * (P<0.05). Vertical error bars represent the standard 
error.  
Figure 4: RT-PCR analysis of CK-2/CK2.1 in PHA stimulated heterozygous rainbow trout tissues.  RT PCR 
analysis showing transcript levels of CK-2 and CK-2.1 in heterozygous rainbow trout tissues after injection with 
50 μg of PHA per 250 g of body weight during a 24-hour time course challenge. The tissues studied include head 
kidney (A), brains (B) and spleen samples from duplicate groups of individuals (C and D). The upper panels 
represent the expression of CK-2/CK-2.1 mRNA while the middle panel is the control, EF1-α. The bar graphs 
below each gel image show the ratio of expression between either CK-2 (grey bars) or CK-2.1 (white bars) and 
the EF1-α amplicons that were used as an internal standard for each time point.    
Figure 5: Protein production of CK-2 in stimulated rainbow trout tissues/RTS-11 and validation of the anti-
CK2 antibody. Protein production of CK-2/CK-2.1 in rainbow trout tissues (A) following 24 h stimulation with 
PHA (i) or PBS control (ii).  Anti-CK2 was also incubated with rCK-2 prior to probing the PHA stimulated rainbow 
trout tissues to ensure that any bands were lost when the antibody was effectively blocked (iii). RTS-11 cultures 
following 24 h PHA stimulation or PBS control in L15 either with or without FBS (B). Further validation regarding 
the specificity of the anti-CK2 antibody (C) with rCK-2 being probed with (i) pre-immune serum, (ii) crude anti-
CK2 at a 1:5000 dilution, (iii) affinity purified anti-CK2 at a 1:50 dilution. The final, purified anti-CK2 antibody 
was also shown to detect both CK-2 and CK-2.1 recombinant protein individually (iv). Molecular weight markers 













Figure 6: The impact of recombinant CK-2 on rainbow trout cell chemotaxis. After exposure to recombinant 
CK-2 protein for 1 hour at concentrations of 1 μg/ml, 50 ng/ml, 100 ng/ml and 500 ng/ml, the chemotaxis of both 
the RTS-11 cell line (A) and primary culture PBLs (B) was observed. Significant differences in chemotaxis 
between CK-2 and truncated β2m of the same concentration are indicated by * (P<0.05). The chemotaxis of RTS-
11 (C) and primary culture PBLs (D) following treatment with pertussis toxin (PTX) at 100 ng/ml prior to 
stimulation with 100 ng/ml of CK-2 for 1 hour. (E) The chemotaxis of rainbow trout PBLs in response to 1 hour 
of stimulation with rCK-2 (500 ng/ml), rCK-2.1 (500 ng/ml) or the mucin stalk alone (1 μg/ml). For all panels, 
truncated β2m (a non-chemokine recombinant protein) and PBS were used as negative controls that would not 
induce chemotaxis, while zymosan activated serum (ZAS) and the complement factor C5a were used as positive 
controls known to induce chemotaxis. For all chemotaxis assays, experiments were repeated a minimum of three 
































































































































Table 1: Primer sequences used in this study.  
 
Primer Name Sequence (5’-3’) Annealing 
Temp. 
Application 
CK-2 sense GCAGAAAAGCTGGTGTCGTG 53oC RT-PCR, genotyping 
CK-2 antisense GGAAGGTACGGATGGAGAAG RT-PCR, genotyping 




CK-2 stalk antisense AGGAGCTTCAGCCATTAGCA Genotyping 
CK-2 stalk SP2 antisense GTTCTACAAGCCCCCATAAG Genotyping 
CK-2 stalk SP4 antisense ATGGGCACATACAATACTGG Genotyping 
EF1-α sense GAGTGAGCGCACAGTAACAC 54oC RT-PCR control 
EF1-α antisense AAAGAGCCCTTGCCCATCTC RT-PCR control 
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